Basics |
Company: |
C4 Therapeutics, Inc. |
IPO Date: |
October 2, 2020 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$224.47M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.54 | 3.81%
|
Avg Daily Range (30 D): |
$0.10 | 2.72%
|
Avg Daily Range (90 D): |
$0.18 | 3.80%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.37M |
Avg Daily Volume (30 D): |
.72M |
Avg Daily Volume (90 D): |
.83M |
Trade Size |
Avg Trade Size (Sh.): |
140 |
Avg Trade Size (Sh.) (30 D): |
120 |
Avg Trade Size (Sh.) (90 D): |
109 |
Institutional Trades |
Total Inst.Trades: |
1,019 |
Avg Inst. Trade: |
$1.93M |
Avg Inst. Trade (30 D): |
$2.88M |
Avg Inst. Trade (90 D): |
$2.21M |
Avg Inst. Trade Volume: |
.19M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.19M |
Avg Closing Trade (30 D): |
$1.2M |
Avg Closing Trade (90 D): |
$1.14M |
Avg Closing Volume: |
176.23K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.7
|
$-.35
|
$-.26
|
Diluted EPS
|
$-1.7
|
$-.35
|
$-.26
|
Revenue
|
$ 33.67M
|
$ 15.36M
|
$ 12.01M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -105.5M
|
$ -24.67M
|
$ -17.72M
|
Operating Income / Loss
|
$ -119.33M
|
$ -28.24M
|
$ -21.44M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.33M
|
$ -13.47M
|
$ -16.55M
|
PE Ratio
|
|
|
|
|